Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

On the prognostic value of Heparin-binding protein in Sepsis

Tverring, Jonas LU orcid (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
Abstract
Sepsis causes major morbidity and mortality worldwide. There is wide consensus that biomarkers have an important role in sepsis research and patient care. Heparin-binding protein (HBP) is a neutrophil-derived, proinflammatory and vascular permeability-inducing protein and a promising novel sepsis biomarker. In this thesis, we investigate some aspects of the prognostic accuracy and added value of single and repeated HBP measurements in plasma at the emergency department (ED) and the intensive care unit (ICU) regarding infection-related organ dysfunction (OD) and sepsis survival.
In Paper I, we conducted a prospective, observational, convenience sample study (NCT02366650) and recruited patients with affected vital signs regardless of... (More)
Sepsis causes major morbidity and mortality worldwide. There is wide consensus that biomarkers have an important role in sepsis research and patient care. Heparin-binding protein (HBP) is a neutrophil-derived, proinflammatory and vascular permeability-inducing protein and a promising novel sepsis biomarker. In this thesis, we investigate some aspects of the prognostic accuracy and added value of single and repeated HBP measurements in plasma at the emergency department (ED) and the intensive care unit (ICU) regarding infection-related organ dysfunction (OD) and sepsis survival.
In Paper I, we conducted a prospective, observational, convenience sample study (NCT02366650) and recruited patients with affected vital signs regardless of infection suspicion at the ED of four centres in three countries in 2015 to 2016. Among 524 included patients, we found that plasma HBP on ED admission had an area under the receiver operating characteristics curve (AUC) of 0.73 (95% CI: 0.68-0.78) to discriminate the pre-specified primary endpoint of infection-induced OD within 72 hours compared to an AUC of 0.82 (0.78-0.86) for C-reactive protein and 0.69 (0.64-0.74) for procalcitonin.
In Paper II, we did a post hoc study including patients with severe sepsis or septic shock and available plasma samples on ICU admission from the prospective, observational FINNAKI study conducted in 17 Finnish ICUs in 2011 to 2012. In a total of 511 patients, addition of plasma HBP to a prediction model including age, simplified acute physiology score II, and creatinine 48 hours pre-ICU increased the AUC from 0.78 (0.73–0.84) to 0.82 (95% CI: 0.77–0.87) regarding the primary endpoint of acute kidney injury (AKI) stage 2-3 from 12 hours up to 5 days.
In Paper III, we conducted an observational, convenience sample study recruiting patients with suspected septic shock at two general mixed ICUs in Skåne, Sweden, and sampled patients for plasma from ICU admission and every 4 hours for 3 days. Among 24 included patients, we found that plasma HBP is highly variable in concentration between 4-hour measurements and that every 100 ng/mL increase in HBP (range 0 to 932 ng/mL) corresponded to 1.4 mmHg decrease in mean arterial pressure in a linear mixed-effects model adjusted for time, noradrenaline dose and vasopressin use (95% CI: -1 to -2.3 mmHg, p=0.04).
In Paper IV, we performed another post hoc investigation of the FINNAKI study, this time including longitudinal sampling for plasma HBP up to seven times during the first five days (hour 0, 12, 24, 36, 48 and day 3 and 5). We pre-published a statistical analysis plan (ISRCTN15560762). In a total of 652 patients, we found that longitudinal HBP adds a small but statistically significant prognostic value to a prediction model (including age, sex, functional performance pre-ICU, sequential organ failure assessment score, lactate and pre-existing chronic health conditions) regarding the primary endpoint of 90-day survival in a complete case analysis (HR 1.06, 95% CI: 1.01 to 1.12, n=576, p=0.019) and in a post-hoc analysis using multiple imputation and nonlinear HBP over time (HR 1.26, 95% CI: 1.11 to 1.43, p<0.001) but not in the pre-specified analysis using multiple imputation and linear HBP over time (HR 1.11, 95% CI: 0.93 to 1.31, p=0.245).
In summary, the findings from this thesis indicate that plasma HBP does not outperform current biomarkers to prognosticate infection-induced OD within 72 hours in patients in the ED with and without suspected infection, that plasma HBP can add prognostic value to known risk factors regarding development of sepsis-related AKI in the ICU, that repeatedly measured plasma HBP concentrations can be highly variable over time during sepsis and that longitundinal HBP adds little prognostic value to known risk factors regarding 90-day survival in ICU patients with sepsis. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • Professor Jensen, Jens Ulrik, University of Copenhagen
organization
publishing date
type
Thesis
publication status
published
subject
keywords
Sepsis, Biomarker, Heparin-binding protein (HBP), Diagnostic accuracy, added value
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
issue
2022:7
pages
105 pages
publisher
Lund University, Faculty of Medicine
defense location
Belfragesalen, BMC D15, Klinikgatan 32 i Lund. Join by Zoom: https://lu-se.zoom.us/j/66749937083
defense date
2022-01-22 09:00:00
ISSN
1652-8220
ISBN
978-91-8021-168-0
language
English
LU publication?
yes
id
6ce27aca-e04b-49d5-b39c-c49c00b79019
date added to LUP
2022-01-03 22:05:41
date last changed
2025-04-04 14:03:24
@phdthesis{6ce27aca-e04b-49d5-b39c-c49c00b79019,
  abstract     = {{Sepsis causes major morbidity and mortality worldwide. There is wide consensus that biomarkers have an important role in sepsis research and patient care. Heparin-binding protein (HBP) is a neutrophil-derived, proinflammatory and vascular permeability-inducing protein and a promising novel sepsis biomarker. In this thesis, we investigate some aspects of the prognostic accuracy and added value of single and repeated HBP measurements in plasma at the emergency department (ED) and the intensive care unit (ICU) regarding infection-related organ dysfunction (OD) and sepsis survival. <br/>In Paper I, we conducted a prospective, observational, convenience sample study (NCT02366650) and recruited patients with affected vital signs regardless of infection suspicion at the ED of four centres in three countries in 2015 to 2016. Among 524 included patients, we found that plasma HBP on ED admission had an area under the receiver operating characteristics curve (AUC) of 0.73 (95% CI: 0.68-0.78) to discriminate the pre-specified primary endpoint of infection-induced OD within 72 hours compared to an AUC of 0.82 (0.78-0.86) for C-reactive protein and 0.69 (0.64-0.74) for procalcitonin. <br/>In Paper II, we did a post hoc study including patients with severe sepsis or septic shock and available plasma samples on ICU admission from the prospective, observational FINNAKI study conducted in 17 Finnish ICUs in 2011 to 2012. In a total of 511 patients, addition of plasma HBP to a prediction model including age, simplified acute physiology score II, and creatinine 48 hours pre-ICU increased the AUC from 0.78 (0.73–0.84) to 0.82 (95% CI: 0.77–0.87) regarding the primary endpoint of acute kidney injury (AKI) stage 2-3 from 12 hours up to 5 days. <br/>In Paper III, we conducted an observational, convenience sample study recruiting patients with suspected septic shock at two general mixed ICUs in Skåne, Sweden, and sampled patients for plasma from ICU admission and every 4 hours for 3 days. Among 24 included patients, we found that plasma HBP is highly variable in concentration between 4-hour measurements and that every 100 ng/mL increase in HBP (range 0 to 932 ng/mL) corresponded to 1.4 mmHg decrease in mean arterial pressure in a linear mixed-effects model adjusted for time, noradrenaline dose and vasopressin use (95% CI: -1 to -2.3 mmHg, p=0.04). <br/>In Paper IV, we performed another post hoc investigation of the FINNAKI study, this time including longitudinal sampling for plasma HBP up to seven times during the first five days (hour 0, 12, 24, 36, 48 and day 3 and 5). We pre-published a statistical analysis plan (ISRCTN15560762). In a total of 652 patients, we found that longitudinal HBP adds a small but statistically significant prognostic value to a prediction model (including age, sex, functional performance pre-ICU, sequential organ failure assessment score, lactate and pre-existing chronic health conditions) regarding the primary endpoint of 90-day survival in a complete case analysis (HR 1.06, 95% CI: 1.01 to 1.12, n=576, p=0.019) and in a post-hoc analysis using multiple imputation and nonlinear HBP over time (HR 1.26, 95% CI: 1.11 to 1.43, p&lt;0.001) but not in the pre-specified analysis using multiple imputation and linear HBP over time (HR 1.11, 95% CI: 0.93 to 1.31, p=0.245).<br/>In summary, the findings from this thesis indicate that plasma HBP does not outperform current biomarkers to prognosticate infection-induced OD within 72 hours in patients in the ED with and without suspected infection, that plasma HBP can add prognostic value to known risk factors regarding development of sepsis-related AKI in the ICU, that repeatedly measured plasma HBP concentrations can be highly variable over time during sepsis and that longitundinal HBP adds little prognostic value to known risk factors regarding 90-day survival in ICU patients with sepsis.}},
  author       = {{Tverring, Jonas}},
  isbn         = {{978-91-8021-168-0}},
  issn         = {{1652-8220}},
  keywords     = {{Sepsis; Biomarker; Heparin-binding protein (HBP); Diagnostic accuracy; added value}},
  language     = {{eng}},
  number       = {{2022:7}},
  publisher    = {{Lund University, Faculty of Medicine}},
  school       = {{Lund University}},
  series       = {{Lund University, Faculty of Medicine Doctoral Dissertation Series}},
  title        = {{On the prognostic value of Heparin-binding protein in Sepsis}},
  url          = {{https://lup.lub.lu.se/search/files/111599725/Jonas_Tvering_web.pdf}},
  year         = {{2022}},
}